Last updated on May 2017

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa


Brief description of study

This survey intends to collect information on key aspects of life with epidermolysis bullosa (EB), including diagnostic journey, treatment, management, daily living challenges, and overall psycho-social, socio-economic, academic and family impact. Objectives: - To understand the unmet needs for people living with EB in the US - To assess the differences/similarities in the management/treatment of EB patients (including wound care, symptom management and other issues) - To assess the EB patients' and caregivers' perceptions of current management/treatment - To assess the challenges and the burden of daily living with EB - To understand EB diagnostic journey (the time to diagnosis and by what type of healthcare provider) - To identify professional disciplines involved in the diagnosis and management of EB - To understand the psycho-social, socio-economic, academic, and family impact of EB

Detailed Study Description

Epidermolysis bullosa (EB) is a rare, often severe genetic disorder characterized by mechanical fragility and blistering or erosion of the skin, mucosa, or epithelial lining of other organs, in response to little or no apparent trauma. EB is chronic, potentially disfiguring, and in some cases fatal. Patients with EB have painful wounds and blisters that can lead to infection and scarring. There are many genetic and symptomatic variations of EB, but all forms share the common symptom of fragile skin that blisters and tears, sometimes from the slightest friction or trauma. There is currently no approved treatment for EB. Current standard of care consists of pain management and the bandaging and cleaning of open wounds to prevent infection. While there are a number of publications/guidance/consensus statements related to the diagnosis and management of EB from the point of view of the health-care provider/disease expert, there is a need for more research to define the key aspects of life with EB (i.e. diagnostic journey, treatment, management, daily living challenges, and overall disease burden) from the perspective of the patient.

Clinical Study Identifier: NCT03158662

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patti Engel, BSN

Amicus Therapeutics
Cranbury, NJ United States
  Connect »